HomeFileCoronary disease

Coronary disease

View Category

Coronary disease

Transfemoral vs Transradial Approach in the Percutaneous Treatment of CTO

Percutaneous treatment of chronic total occlusion (CTO) has traditionally been via the transfemoral approach (TFA). The use...
solaci -
Learn More
Chronic Ischemic cardiopathy

Improved Ventricular Function Post Revascularization: Fewer Events across Subgroups?

According to the STITCH and STITCHES trials, in patients with coronary artery disease and deteriorated left ventricular...
solaci -
Learn More
Coronary disease

Should We Worry about Non-Ischemic Lesions?

In the last decade, the interest in atheroma plaque morphology and its role in clinical events has...
solaci -
Learn More
Coronary disease

Coronary Flow Reserve in Patients with Intermediate FFR: Should We Use This Tool to Define When to Perform Coronary Angioplasty?

Current guidelines recommend using fractional flow reserve (FFR) to guide coronary angioplasty. However, intermediate FFR values (0.75-0.80)...
solaci -
Learn More
Acute coronary syndromes

Should We Start Using OCT in Myocardial Infarction with Non-Obstructive Lesions?

In ST elevation MI, the common assessment methodology continues to the angiography; however, we all know it...
solaci -
Learn More
Chronic Ischemic cardiopathy

Can the Use of Intra Arterial Vasodilators Prevent Radial Artery Occlusion?

The incidence of post procedure radial occlusion (RAO) ranges from 1% to 12 % according to some...
solaci -
Learn More
Acute coronary syndromes

Coronary Angioplasty Evolution According to Syntax II: 5-Year Followup

It has been long since the SYNTAX (NEJM 2009) came out comparing percutaneous coronary intervention (PCI) against...
solaci -
Learn More
Acute coronary syndromes

Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus after ST-Segment Elevation Acute Coronary Syndrome

The incidence of left ventricular thrombosis (LVT) after anterior ST-segment elevation myocardial infarction (STEMI) ranges from 4%...
solaci -
Learn More